{
  "id": "clinical#screening_cues_1baf8198",
  "content": "chronic pain.\n• Serious medical complications of opioid withdrawal are rare. Fluid depletion may\noccasionally lead to renal impairment. Death during opioid withdrawal is very\nuncommon.\nDiagnostic requirements for disorders due to substance use | Substance withdrawal\n486 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders\nTable 6.16. contd\nSubstance\nSubstance-specific features of withdrawal\nSedatives, hypnotics Presenting features of sedative, hypnotic or anxiolytic withdrawal may include anxiety,\nor anxiolytics psychomotor agitation, insomnia, increased hand tremor, nausea or vomiting, and\ntransient visual, tactile or auditory illusions or hallucinations. There may be signs of\nautonomic hyperactivity (e.g. tachycardia, hypertension, perspiration) or postural\nhypotension. The withdrawal state may be complicated by seizures.\nAdditional features\n• The severity and time course of sedative, hypnotic or anxiolytic withdrawal is\nrelated to the particular substance taken, its half-life and duration of action, and the\namount, frequency and duration of use before cessation or reduction of use.\n• The withdrawal state associated with short-acting drugs typically has its onset\nwithin 12–24 hours after cessation of use and has a course of up to 14 days.\nWithdrawal onset may be delayed by 3–5 days with longer-acting drugs and may\npersist for several weeks.\n• Sedative, hypnotic or anxiolytic withdrawal may be complicated by seizures, which",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "sleep",
      "stress",
      "screening_cues"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues chronic pain.\n• Serious medical complications of opioid withdrawal are rare. Fluid depletion may\noccasionally lead to renal impairment. Death during opioid withdrawal is very\nuncommon.\nDiagnostic requirements for disorders due to substance use | Substance withdrawal\n486 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders\nTable 6.16. contd\nSubstance\nSubstance-specific features of withdrawal\nSedatives, hypnotics Presenting features of sedative, hypnotic or anxiolytic withdrawal may include anxiety,\nor anxiolytics psychomotor agitation, insomnia, increased hand tremor, nausea or vomiting, and\ntransient visual, tactile or auditory illusions or hallucinations. There may be signs of\nautonomic hyperactivity (e.g. tachycardia, hypertension, perspiration) or postural\nhypotension. The withdrawal state may be complicated by seizures.\nAdditional features\n• The severity and time course of sedative, hypnotic or anxiolytic withdrawal is\nrelated to the particular substance taken, its half-life and duration of action, and the\namount, frequency and duration of use before cessation or reduction of use.\n• The withdrawal state associated with short-acting drugs typically has its onset\nwithin 12–24 hours after cessation of use and has a course of up to 14 days.\nWithdrawal onset may be delayed by 3–5 days with longer-acting drugs and may\npersist for several weeks.\n• Sedative, hypnotic or anxiolytic withdrawal may be complicated by seizures, which Chronic pain. • serious medical complications of opioid withdrawal are rare."
}